Examkin

Soru

Zorluk: OrtaPreventive Care and Immunizations

A 12-month-old girl is brought to the pediatric clinic for a routine health maintenance evaluation. She was born at 39 weeks of gestation via spontaneous vaginal delivery to a mother with poorly controlled HIV infection, and the patient was subsequently diagnosed with perinatal HIV at age 2 months. The patient is currently asymptomatic and her mother reports strict adherence to the prescribed antiretroviral therapy. Vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), heart rate 110/min, respiratory rate 24/min, and blood pressure 85/55 mm Hg. Physical examination reveals an active, well-nourished child with normal growth parameters and no lymphadenopathy or hepatosplenomegaly. Laboratory studies from two weeks ago demonstrate a CD4+ T-lymphocyte count of 1,250/mm31,250/\text{mm}^3 and a CD4 percentage of 28%28\%. Her immunizations are up to date and have consisted entirely of age-appropriate inactivated vaccines. The mother asks whether her daughter can receive the measles, mumps, and rubella (MMR) and varicella vaccines today. Which of the following is the most appropriate action?

  1. Administer the MMR vaccine and the varicella vaccine as separate injections todayCevap
  2. B
    Administer the quadrivalent measles, mumps, rubella, and varicella (MMRV) combined formulation today
  3. C
    Defer the MMR and varicella immunizations indefinitely due to her perinatal diagnosis
  4. D
    Postpone the MMR and varicella vaccines until she is at least 24 months of age
  5. E
    Give the MMR vaccine today but postpone the varicella immunization indefinitely

Cevap

Administer the MMR vaccine and the varicella vaccine as separate injections today.
The correct action is to administer the MMR and varicella vaccines as separate injections today. Children with perinatal HIV infection who do not have severe immunosuppression should receive the standard live-attenuated vaccines (MMR and varicella) at the routine age of 12-15 months. In children under 5 years old, a CD4 percentage ≥15%\ge 15\% indicates adequate immune function to safely receive these vaccines. However, they must be administered as separate injections. The combined MMRV vaccine contains a significantly higher titer of the varicella vaccine virus than the single-antigen varicella vaccine and is strictly contraindicated in all HIV-infected patients, regardless of their CD4 count, to prevent vaccine-strain viral dissemination.

Adım Adım Çözüm

1
Evaluate the patient's immune status for live-attenuated vaccine eligibility.
The CD4 percentage is 28%, which is greater than the 15% threshold that defines severe immunosuppression in children under 5 years of age.
HIV-infected children can receive standard live vaccines (such as MMR and varicella) only if they do not exhibit severe immunosuppression.
2
Determine the appropriate formulation for administering the MMR and varicella vaccines in an eligible HIV patient.
The vaccines must be administered as two separate injections rather than the combination vaccine.
The combined MMRV vaccine is strictly contraindicated in all HIV-infected individuals due to its high titer of the varicella vaccine virus, which poses an increased risk of disseminated disease.

Anahtar Kavram

HIV-infected children without severe immunosuppression (CD4 percentage ≥15%\ge 15\% for ages 1-5 years) should receive the MMR and varicella vaccines on the standard schedule, but they must be administered as separate injections because the combined MMRV formulation is contraindicated.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru